Healthcare -
Biotechnology - NASDAQ - US
$ 115.69
1.08 %
$ 11.1 B
Market Cap
75.12
P/E
SRPT - DEPRECIATION & AMORTIZATION
Depreciation & Amortization SRPT - Sarepta Therapeutics, Inc.
44.4 M
LAST VALUE
8.07%
2 YEAR CAGR
29.38%
5 YEAR CAGR
42.60%
10 YEAR CAGR